A. Cipriani, United Kingdom

University of Oxford Department of Psychiatry
Andrea Cipriani is Professor of Psychiatry and NIHR Research Professor at the Department of Psychiatry, University of Oxford, and Honorary Consultant Psychiatrist at Oxford Health NHS Foundation Trust. His main interest in psychiatry is evidence-based mental health and his research focuses on the evaluation of treatments in psychiatry, mainly major depression, bipolar disorder and schizophrenia. His research in the methodology of evidence synthesis has now a specific focus on individual patient data network meta-analysis and data science, trying to assess the validity, breadth, structure and interpretation of innovative statistical and machine learning approaches to better inform the decision-making process between patients and clinicians and personalise treatment indications in routine clinical care. Prof Cipriani is currently the Director of the NIHR Oxford cognitive health Clinical Research Facility, Lead of the Digital and Informatics Theme of the Oxford Health Biomedical Research Centre and the Editor in Chief of Evidence-Based Mental Health (https://ebmh.bmj.com/). Twitter account: @And_Cipriani

Moderator Of 2 Sessions

Date
Tue, 13.04.2021
Session Time
10:00 - 11:30
Room
Channel 2
Session Description
This research symposium aims to present the quintessence of current scientific evidence on personalized psychiatry and its place in clinical practice. This symposium will bring together international experts in all major areas of personalized medicine in psychiatry. The main educational objective of the symposium is not only to present the results of up-to-date research in the field of personalized medicine in psychiatry, but also to demonstrate the possibility of translating findings from research into clinical practice, as well as to show the current perspectives and priorities for further research.
Session Icon
Live, ECP Session
Industry Session
Date
Sun, 11.04.2021
Session Time
13:30 - 15:00
Room
Industry 2
Session Description
LIVE SESSION - Caring for patients with schizophrenia in the digital era - SUPPORTED BY Angelini Pharma

Session Description:

Scientific Rationale:

The focus on adolescent health has been increasing in recent years, with a growing recognition that these years are pivotal in the development and maintenance of health behaviours and outcomes through the life course. Adolescence is a key period for mental health disorder onset, with half of lifetime onset by age. Research over previous decades suggests that the prevalences of mental health problems are increasing in teenagers across different countries. Generally, young patients, particularly those with schizophrenia, may have peculiar needs in terms of treatment, both non-pharmacological and pharmacological. This requires a specific focus on shared decision making, involving patients and caregivers in the treatment process starting from the definition of treatment goals. A proper control of symptoms is essential, nevertheless it is clear that quality of life and functionality should represent a primary target for patients with schizophrenia, caregivers and physicians. A new opportunity for the diagnosis and treatment of schizophrenia in young patients is represented by digital tools. There is a growing field of research that is highlighting the potential effect of digital tools in the whole clinical management of patients, being the young patients particularly keen to the use of digital opportunities. The digital approach already showed to be useful to guarantee a minimum level of care during the COVID pandemic, e.g. telepsychiatry, nevertheless it seems to be a promising option beyond the pandemic because it can promote a patient-centric mindset, empowering patients with schizophrenia and their caregivers.

Session Icon
Live

Presenter Of 6 Presentations

Industry Session not Included in the Main Event CME / CPD Credit (ID 1126) No Topic Needed

Live Q&A

Session Icon
Live
Date
Sun, 11.04.2021
Session Time
13:30 - 15:00
Room
Industry 2
Lecture Time
14:40 - 14:55
Industry Session not Included in the Main Event CME / CPD Credit (ID 1126) No Topic Needed

Closing Remarks

Session Icon
Live
Date
Sun, 11.04.2021
Session Time
13:30 - 15:00
Room
Industry 2
Lecture Time
14:55 - 15:00
LIVE - ECP Symposium: Personalised Psychiatry: Hype or Hope? (ID 838) No Topic Needed

Live Q&A

Session Icon
Live, ECP Session
Date
Tue, 13.04.2021
Session Time
10:00 - 11:30
Room
Channel 2
Lecture Time
11:08 - 11:28
LIVE - Symposium: Network Analysis for Personalisation of Treatment: Understanding Links Among Symptoms, Risk Factors and Functioning (ID 639) No Topic Needed
Industry Session not Included in the Main Event CME / CPD Credit (ID 1126) No Topic Needed

Welcome & Opening Remarks

Session Icon
Live
Date
Sun, 11.04.2021
Session Time
13:30 - 15:00
Room
Industry 2
Lecture Time
13:30 - 13:40
LIVE - Symposium: Network Analysis for Personalisation of Treatment: Understanding Links Among Symptoms, Risk Factors and Functioning (ID 639) No Topic Needed

S0171 - Network Meta-analysis of Antidepressant Efficacy: Perspective and Challenges for Personalisation of Care

Session Icon
Live
Date
Tue, 13.04.2021
Session Time
17:30 - 19:00
Room
Channel 1
Lecture Time
18:04 - 18:21